Hjerteinsufficiens er hyppigere rapporteret, når pioglitazon bruges i kombinationsbehandling med insulin eller hos patienter med tidligere hjerteinsufficiens.
Heart failure has been reported rarely with marketing use of pioglitazone, but more frequently when pioglitazone was used in combination with insulin or in patients with a history of cardiac failure.